| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267345.1 |
Tanespimycin |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024447907 |
Resistant |
| ENSG00000267345.1 |
Tanespimycin |
Chronic Lymphocytic Leukemia |
0.023087859 |
Resistant |
| ENSG00000267345.1 |
Tanespimycin |
Brain lower grade glioma |
0.037692284 |
Resistant |
